The 2022 China Rare Disease Conference was successfully held in Beijing from October 28th to November 4th in a "online+offline" format. The theme of this conference is "putting life first and sharing health". More than hundreds of experts in rare disease policy formulation, clinical diagnosis and treatment, drug research and development, and other fields from home and abroad, based on Chinese characteristics and from a global perspective, conducted in-depth and comprehensive exchanges around rare disease prevention and protection policies, drug innovation and research and development, new progress in clinical diagnosis and treatment, real world research and interdisciplinary development, and other topics.

 On the afternoon of the 30th, Su Ying, General Manager of Aibo Intelligence, was invited to participate in the online conference on "Innovative Diagnosis and Treatment of Rare Neurological Diseases in the Context of Medical and Industrial Integration". I shared the current development status and product development progress of iBo Intelligence with colleagues and experts, discussed and exchanged ideas, analyzed various challenges faced in the field of rehabilitation, and helped improve the research and promotion of rehabilitation products.